Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

18.18 +0.27 (+1.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 655,158
Open 18.00
Bid (Size) 18.00 (100)
Ask (Size) 18.18 (200)
Prev. Close 17.91
Today's Range 17.80 - 18.59
52wk Range 7.900 - 20.33
Shares Outstanding 49,471,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗
A newly public real-estate platform is putting up numbers that look far more seasoned than its age. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗
One fund just made a bold bet on a telecom stock undergoing a big transformation 
Via The Motley Fool

Performance

YTD
+95.9%
+95.9%
1 Month
-1.7%
-1.7%
3 Month
+25.6%
+25.6%
6 Month
+71.0%
+71.0%
1 Year
+87.2%
+87.2%

More News

Read More
News headline image
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For November 10, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For February 26, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
Via Benzinga
News headline image
Unveiling 4 Analyst Insights On Theravance Biopharma ↗
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For Theravance Biopharma ↗
Via Benzinga
News headline image
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗
Via The Motley Fool
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Here's Why Shares in Theravance Biopharma Exploded Today ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Theravance Biopharma Inc (NASDAQ:TBPH) Reports Q3 2025 Earnings Beat Amid Muted Market Reaction ↗
Via Chartmill
Topics Earnings
News headline image
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
From Theravance Biopharma
Via Business Wire
News headline image
This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday ↗
Via Benzinga
News headline image
Theravance Sales Jump 83 Percent ↗
Via The Motley Fool
News headline image
Theravance Biopharma Inc (NASDAQ:TBPH) Misses Q2 2025 Revenue and EPS Estimates Amid Mixed Market Reaction ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For August 12, 2025 ↗
Via Benzinga
News headline image
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
Via Benzinga
News headline image
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE

Frequently Asked Questions

Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?
Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.
What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?
Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?
The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market
What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?
The current price of Theravance Biopharma, Inc. - Ordinary Shares is 18.18
When was Theravance Biopharma, Inc. - Ordinary Shares last traded?
The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 12/18/25 04:00 PM ET
What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?
The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 899.38M
How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?
Theravance Biopharma, Inc. - Ordinary Shares has 899M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.